Controversial and unresolved issues in the classification of surgically implanted biological heart valve prostheses (problem lecture)
- 12 January 2026
- journal article
- Published by Cardiology Research Institute in Siberian Journal of Clinical and Experimental Medicine
- Vol. 40 (4)
Abstract
One of the significant areas of cardiac surgery is the replacement of damaged or faulty heart valves. Biological heart valve prostheses created from biological tissues represent a significant achievement in this area, providing effective treatment and improving the quality of life of patients. Aim: To analyze and discuss unresolved issues in the classification of surgically implanted biological heart valve prostheses. Various approaches to the classification of biological heart valve prostheses are presented, including from the standpoint of their historicity. Particular attention is paid to the prospects for the development of combined technologies in the creation of heart valve prostheses. Thus, the rapid development of biological and engineering technologies makes significant adjustments to the very concept of “biological heart valve prosthesis”. A transformation in the production of these medical devices is expected, which is already associated with the development and implementation of bioengineering technologies in clinical practice, which may lead to the abandonment of existing methods of production and use of biopolymers (collection from animals and fixation /sterilization /storage in glutaraldehyde or a similar agent). It is obvious that in the near future, synthetic, combined bioprostheses and valves created on the basis of promising tissue engineering technologies will appear. Innovative tissue and cell prostheses already include structures created from patient cells or using bioprinting. In general, these technologies are aimed at creating prostheses that can have an ideal match to the patient's anatomy and minimize the risk of rejection. Such valves are likely to be stronger, less likely to cause complications and easier to implant.Keywords
This publication has 38 references indexed in Scilit:
- Five-year Outcomes of the COMMENCE Trial Investigating Aortic Valve Replacement With RESILIA TissueThe Annals of Thoracic Surgery, 2022
- Xenopericardial Graft Selection for Valve Apparatus of Transcatheter Heart Valve BioprosthesisBiomedical Engineering, 2016
- Very Long-Term Outcomes of the Carpentier-Edwards Perimount Aortic Valve in Patients Aged 60 or YoungerThe Annals of Thoracic Surgery, 2015
- Very late outcomes for mitral valve replacement with the Carpentier-Edwards pericardial bioprosthesis: 25-year follow-up of 450 implantationsThe Journal of Thoracic and Cardiovascular Surgery, 2014
- Isolated aortic valve replacement in North America comprising 108,687 patients in 10 years: Changes in risks, valve types, and outcomes in the Society of Thoracic Surgeons National DatabaseThe Journal of Thoracic and Cardiovascular Surgery, 2009
- Prosthetic heart valves: Catering for the fewBiomaterials, 2008
- Clinical experience with stentless pericardial aortic monopatch for aortic valve replacementThe Journal of Thoracic and Cardiovascular Surgery, 1987
- Clinical durability of the Hancock porcine bioprosthetic valveThe Journal of Thoracic and Cardiovascular Surgery, 1980
- Spontaneous Degeneration of Porcine Bioprosthetic ValvesThe Annals of Thoracic Surgery, 1980
- Hemodynamic and clinical comparison of the Hancock modified orifice and standard orifice bioprostheses in the aortic positionThe Journal of Thoracic and Cardiovascular Surgery, 1980